Candriam S.C.A. Cytom X Therapeutics, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$1.21 - $5.13 $254,132 - $1.08 Million	210,027 New	210,027 $256,000
Q1 2022 May 13, 2022	SELL	$2.67 - $4.68 $285,513 - $500,451	-106,934 Reduced 6.07%	1,653,988 $4.42 Million
Q4 2021 Feb 10, 2022	SELL	$3.87 - $7.39 $5.98 Million - $11.4 Million	-1,545,018 Reduced 46.73%	1,760,922 $7.62 Million
Q3 2021 Nov 09, 2021	BUY	$4.32 - $6.43 $4.22 Million - $6.29 Million	977,587 Added 41.99%	3,305,940 $16.8 Million
Q2 2021 Jul 20, 2021	BUY	$6.33 - $9.91 $14.7 Million - $23.1 Million	2,328,207 Added 1594662.38%	2,328,353 $14.7 Million
Q1 2021 Apr 29, 2021	BUY	$6.6 - $9.0 $963 - $1,314	146 New	146 $1,000
Q2 2020 Jul 23, 2020	SELL	$7.4 - $14.64 $5.48 Million - $10.9 Million	-741,191 Closed	0 $0
Q1 2020 May 26, 2020	BUY	$3.61 - $8.6 $169 - $404	47 Added 0.01%	741,191 $6.02 Million
Q4 2019 Jan 21, 2020	BUY	$5.17 - $8.91 $275,617 - $475,001	53,311 Added 7.75%	741,144 $6,000
Q2 2019 Aug 01, 2019	BUY	$9.35 - $11.41 $177,650 - $216,790	19,000 Added 2.84%	687,833 $7.68 Million
Q1 2019 May 02, 2019	BUY	$9.5 - $19.16 $1.69 Million - $3.41 Million	177,845 Added 36.22%	668,833 $7.19 Million
Q4 2018 Feb 14, 2019	BUY	$12.69 - $18.61 $1.25 Million - $1.83 Million	98,261 Added 25.02%	490,988 $7.41 Million
Q3 2018 Nov 07, 2018	BUY	$18.04 - $26.41 $3.84 Million - $5.61 Million	212,600 Added 118.03%	392,727 $7.27 Million
Q2 2018 Aug 14, 2018	BUY	$21.38 - $29.68 $2.97 Million - $4.13 Million	139,127 Added 339.33%	180,127 $4.12 Million
Q1 2018 May 09, 2018	SELL	$21.76 - $34.22 $1.04 Million - $1.64 Million	-48,000 Reduced 53.93%	41,000 $1.17 Million
Q4 2017 Feb 07, 2018	SELL	$19.0 - $23.09 $1.44 Million - $1.75 Million	-76,000 Reduced 46.06%	89,000 $1.88 Million
Q3 2017 Nov 03, 2017	BUY	$13.53 - $18.17 $2.23 Million - $3 Million	165,000	165,000 $3 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.4M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$7.81 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$5.23 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$5.16 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$4.81 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$3.1 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $66M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account